As medical director for Homeless Health Care Los Angeles, where I
run a clinic at a needle exchange on Skid Row, and as a staff physician
at the free Venice Family Clinic, where 25% of our patients are
homeless, I treat wounds and abscesses on about 10 patients per week
("MRSA Showing No Mercy in Skin Infections," Oct. 1, 2007, p.
41).
I'm not sure why Dr. Mark Lebwohl recommends doxycycline or
minocycline as "the top choices" when he already admitted that
trimethoprim-sulfamethoxazole "still works almost everywhere."
In my experience, TS is inexpensive and well tolerated, and it works
very well and quickly. Doxycycline usually has higher resistance rates
and works more slowly.
Dr. Lebwohl also recommends routine culture and sensitivity
testing, which might be appropriate in an inpatient scenario, but since
methicillin-resistant Staphylococcus aureus is so ubiquitous in the
community, this is just an added expense to a clinic. We assume the
abscesses and cellulitis we see are caused by MRSA and we treat
accordingly. I treat all my patients on Skid Row with TS and get great
results. In fact, if the abscess is small enough (less than 5 cm), using
antibiotics alone is usually adequate instead of incision and drainage.
The study that showed antibiotics weren't helpful and that I &
D was recommended as first line only also made this recommendation for
abscesses less than 5 cm. Thus, I agree with Dr. Lebwohl to be liberal
with the use of antibiotics because most large abscesses will have a
significant amount of cellulitis that will not improve with I & D
alone.
Susan Partovi, M.D.
Los Angeles
LETTERS
Letters in response to articles in INTERNAL MEDICINE NEWS and its
supplements should include your name and address, affiliation, and
conflicts of interest in regard to the topic discussed. Letters may be
edited for space and clarity.
Mail: Letters, INTERNAL MEDICINE NEWS, 5635 Fishers Lane, Suite
6000, Rockville, MD 20852
Fax: 240-221-2541
E-mail: imnews@elsevier.com
COPYRIGHT 2007 International Medical News
Group Reproduced with permission of the copyright holder. Further reproduction or distribution is prohibited without permission.
Copyright 2007 Gale, Cengage Learning. All rights
reserved. Gale Group is a Thomson Corporation Company.
NOTE: All illustrations and photos have been removed from this article.